Bioactive Materials (Aug 2024)

Enhanced pyroptosis induction with pore-forming gene delivery for osteosarcoma microenvironment reshaping

  • Jing-Jun Nie,
  • Bowen Zhang,
  • Peng Luo,
  • Maoguo Luo,
  • Yuwen Luo,
  • Jingjing Cao,
  • Honggang Wang,
  • Jianping Mao,
  • Yonggang Xing,
  • Weifeng Liu,
  • Yuning Cheng,
  • Renxian Wang,
  • Yajun Liu,
  • Xinbao Wu,
  • Xieyuan Jiang,
  • Xiaoguang Cheng,
  • Chi Zhang,
  • Da-Fu Chen

Journal volume & issue
Vol. 38
pp. 455 – 471

Abstract

Read online

Osteosarcoma is the most common malignant bone tumor without efficient management for improving 5-year event-free survival. Immunotherapy is also limited due to its highly immunosuppressive tumor microenvironment (TME). Pore-forming gasdermins (GSDMs)-mediated pyroptosis has gained increasing concern in reshaping TME, however, the expressions and relationships of GSDMs with osteosarcoma remain unclear. Herein, gasdermin E (GSDME) expression is found to be positively correlated with the prognosis and immune infiltration of osteosarcoma patients, and low GSDME expression was observed. A vector termed as LPAD contains abundant hydroxyl groups for hydrating layer formation was then prepared to deliver the GSDME gene to upregulate protein expression in osteosarcoma for efficient TME reshaping via enhanced pyroptosis induction. Atomistic molecular dynamics simulations analysis proved that the hydroxyl groups increased LPAD hydration abilities by enhancing coulombic interaction. The upregulated GSDME expression together with cleaved caspase-3 provided impressive pyroptosis induction. The pyroptosis further initiated proinflammatory cytokines release, increased immune cell infiltration, activated adaptive immune responses and create a favorable immunogenic hot TME. The study not only confirms the role of GSDME in the immune infiltration and prognosis of osteosarcoma, but also provides a promising strategy for the inhibition of osteosarcoma by pore-forming GSDME gene delivery induced enhanced pyroptosis to reshape the TME of osteosarcoma.

Keywords